New year pharmaceutical companies break the cocoon of a Butterfly nirvana.doc

 PAGE \* MERGEFORMAT 8 New year pharmaceutical companies break the cocoon of a Butterfly nirvana Facing the new year, the pharmaceutical policy environment, China’s pharmaceutical enterprises moment of tension-sensitive nerve, remained significant when the fragile, but real strong, the body to regulate the body to adapt to changes in the industry, while those prescient insight business opportunities, do not give up easily and can adjust. The number of pharmaceutical enterprises, especially small and medium pharmaceutical companies, moderate changes in the marketing machine adjustment and innovation in the new year, which is how the “transformation into a butterfly,” key. The marketing is always dynamic, a different ownership, corporate culture, organizational structure, performance system, the sales team’s success will make a difference, success can not be copied, only a reference! Involved in the retail terminal is king Changes in the environment with the past, pharmaceutical companies open the door of the hospital market, “sales of gold” has been hard work, along with the increasingly regulated pharmaceutical market, many pharmaceutical companies have become the change of marketing strategy and objectives the main force in the transfer market, and more numerous for the pharmaceutical market environment changes, the necessary breakthroughs in the new year, good new “nirvana.” Current situation from the industry, due to the control of drug distribution areas, down between the layers before distribution through agents marketing can no longer work. And only firmly grasp the terminal market, with the “terminal is king” marketing mode and means are still regarded as drug companies an effective means to achieve one of stable growth. For many companies started to establish their own marketing team or commercial companies, although the strength of the pharmaceutical companies demanding their own, need a lot of money to build, but with the national policy on t